Massive 14,000-Patient review aims to map China's breast cancer care
NCT ID NCT07476170
Summary
This study aims to understand how advanced breast cancer is actually treated in China by analyzing the medical records of 14,000 patients. It will look at which drugs are used first, how long treatments last, and what side effects patients experience. The goal is to gather real-world evidence to see if treatments are working as expected in everyday clinical practice.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HR+/HER2- ADVANCED OR METASTATIC BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Conditions
Explore the condition pages connected to this study.